Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Soliciting Broad Range Of Comments From Industry On Regulatory Reform

Sep 08 2017

• By Michael Cipriano

StacksOfPapers_1200x675

Related Content

Gottlieb Nomination As US FDA Chief Could Signal Changes To Generic Approval Process

Mar 13 2017

FDA Getting Reg Slashing Directive In Trump Executive Order

Jun 24 2017

FDA's Orphan Designation Backlog Plan Focuses On Efficiency, Not Staff

Jun 29 2017

US FDA Likely Not 'Significant', Could Be Mostly Spared From Trump's Regulation-Slashing Order

Feb 10 2017

Trump Slams FDA Regulations In Joint Session Of Congress

Mar 01 2017

FDA's Off-Label Communication Changes Should Start With Payers – PhRMA

Sep 20 2016

Additional Topics

United States FDA Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window